Steady-State Pharmacokinetics of Tedizolid in Plasma and Sputum of Patients With Cystic Fibrosis
Phase of Trial: Phase IV
Latest Information Update: 08 Oct 2017
At a glance
- Drugs Tedizolid (Primary) ; Tedizolid (Primary)
- Indications Cystic fibrosis
- Focus Pharmacokinetics
- 08 Oct 2017 Results (n=6) assessing pharmacokinetics of IV/PO tedizolid in plasma in patients presented at the IDWeek 2017.
- 28 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
- 28 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Dec 2017.